Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide is a dual GIP/GLP-1 agonist, meaning it activates two receptor types instead of one
Cross-contamination between vials, while unlikely with proper technique, represents a risk that increases with protocol complexity
If a patient reports new ED after starting a GLP-1 RA, it is worth evaluating other factors (changes in weight, blood pressure, medication interactions, psychological factors, etc.)
The degree of receptor activation is typically reported as the peptide concentration required for a response to reach 50% of its maximal value, known as the half-maximal effective concentration (EC 50 )
US$ 20.45
US$ 20.64
US$ 22.62
US$ 25.94
US$ 25.47
US$ 22.67
US$ 28.55
US$ 27.50
